p53 has been shown to regulate the expression of both αB-crystallin and HspB2, and silencing expression of αB-crystallin, but not HspB2, in MCF-7 breast cancer cells leads to higher intracellular glucose levels [15]. The gene discussed is HSPB2; the disease is breast cancer.